Marathon Petroleum (NYSE:MRO): Credit Suisse downgraded Marathon Petroleum to Neutral from Outperform due to a falling capture rates given RINs and weak asphalt margins.
ConAgra (NYSE:CAG): Citigroup believes that most of today’s lowered outlook announcement is priced into ConAgra shares and sees good growth for the company going forward. Citi sees upside in ConAgra shares going forward and keeps a Buy rating on the name, with a slightly lowered price target of $40.
Five Below (NASDAQ:FIVE): UBS believes that Five Below reported very good second quarter results, while its guidance is likely conservative. The firm expects the company to benefit from the popularity of its rubber band bracelets, and from easier comps over the next few quarters. UBS keeps a Buy rating on the stock.
Mylan (NASDAQ:MYL): Bernstein upgraded Mylan to Outperform from Market Perform citing higher probability of winning approval for a generic of GlaxoSmithKline’s (NYSE:GSK) Advair by mid-2016 following yesterday’s FDA draft guidance. The firm raised its price target on the shares to $44 from $35.